A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia

Published:2017-11-21 Issue:2 Volume:93 Page:254-261
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

DeAngelo Daniel J.¹,Brunner Andrew M.²^ORCID,Werner Lillian¹,Avigan David³,Fathi Amir T.²,Sperling Adam S.¹,Washington Abigail³,Stroopinsky Dina³^ORCID,Rosenblatt Jacalyn³,McMasters Malgorzata³,Luptakova Katarina⁴,Wadleigh Martha¹,Steensma David P.¹,Hobbs Gabriela S.²,Attar Eyal C.⁵,Amrein Philip C.²,Ebert Benjamin L.¹,Stone Richard M.¹,Ballen Karen K.⁶

Affiliation:

1. Dana-Farber Cancer Institute; Boston Massachusetts

2. Massachusetts General Hospital; Boston Massachusetts

3. Beth-Israel Deaconess Medical Center; Boston Massachusetts

4. Takeda Oncology, Cambridge; Cambridge MA

5. Agios Pharmaceuticals, Cambridge; Cambridge MA

6. University of Virginia; Charlottesville Virginia

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24968/fullpdf

Reference39 articles.

1. Progress and strategies for patients with relapsed and refractory acute myeloid leukemia;Litzow;Curr Opin Hematol.,2007

2. Prognostic index for adult patients with acute myeloid leukemia in first relapse;Breems;J Clin Oncol.,2005

3. Treatment of relapsed and refractory acute myelogenous leukemia;Estey;Leukemia.,2000

4. Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse;Kurosawa;Haematologica.,2010

5. Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes;Kebriaei;Bone Marrow Transplant.,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis-Related Gene Signature for Prognosis Prediction in Acute Myeloid Leukemia and Potential Therapeutic Options;International Journal of General Medicine;2024-09

2. Real-World Risk of Severe Cytopenias in Multiple Myeloma Patients Sequentially Treated with Immunomodulatory Drugs;Acta Haematologica;2024-05-10

3. Unlocking the Power of Immune Microenvironment in AML Therapy: Current Insight and Future Prospects;Interdisciplinary Cancer Research;2024

4. Safety and tolerability of lenalidomide maintenance in post-transplant acute myeloid leukemia and high-risk myelodysplastic syndrome;Bone Marrow Transplantation;2021-09-01

5. Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide;Nature Reviews Clinical Oncology;2021-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3